Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Brain Neoplasms × Eflornithine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Adenomatous Polyposis Coli 2 Urinary Bladder Neoplasms 1 Precancerous Conditions 1 Glioma 1 Colonic Polyps 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Radiosurgery 21 Radiotherapy 19 Temozolomide 16 Lomustine 9 Bevacizumab 7 Surgical Procedures, Operative 6 Procarbazine 6 Vincristine 5 Nivolumab 5 Memantine 4 Filgrastim 4 Etoposide 4 Cisplatin 4 Carboplatin 4 Sodium Chloride 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Cyclophosphamide 3 Corticotropin-Releasing Hormone 3 Carmustine 3 icotinib 2 etoposide phosphate 2 efaproxiral 2 X-Rays 2 Tranexamic Acid 2 Tf-CRM107 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02796261 2022-01-21

STELLAR

Orbus Therapeutics, Inc.

Phase 3 Unknown

Astrocytoma, Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡